SCHEMBL24353218

SCHEMBL24353218

CCCNc1nc(CN(C)Cc2cccc(OC)c2)nc2sc(C)c(C)c12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.46
▸ HTT P42858 3/20 0.46
▸ LMNA P02545 3/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ NPSR1 Q6W5P4 2/20 0.42
▸ PLA2G1B P04054 1/20 0.42
▸ ATG4B Q9Y4P1 1/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ RAF1 P04049 1/20 0.42
▸ PKM P14618 1/20 0.40
▸ PDE4A P27815 1/20 0.40
▸ PDE4B Q07343 1/20 0.40
▸ PDE4C Q08493 1/20 0.40
▸ PDE4D Q08499 1/20 0.40
▸ PDE3B Q13370 1/20 0.40
▸ PDE3A Q14432 1/20 0.40
▸ MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24353318 0.91 ALDH1A1 (0.48) ALDH1A1HTTLMNAKDM4ETDP1
SCHEMBL24353221 0.90 PDE4A (0.45) ALDH1A1HTTLMNAKDM4ETDP1
SCHEMBL24353227 0.90 ALDH1A1 (0.44) ALDH1A1HTTLMNAKDM4ETDP1
SCHEMBL24353322 0.89 ALDH1A1 (0.46) ALDH1A1HTTLMNAKDM4ETDP1
SCHEMBL24353182 0.88 ALDH1A1 (0.44) ALDH1A1HTTLMNAKDM4ETDP1
SCHEMBL24353229 0.87 ALDH1A1 (0.43) ALDH1A1HTTLMNAKDM4ETDP1
SCHEMBL18456744 0.87 ALDH1A1 (0.43) ALDH1A1HTTLMNAKDM4ETDP1
SCHEMBL24353215 0.87 ALDH1A1 (0.46) ALDH1A1HTTLMNAKDM4ETDP1
SCHEMBL18457051 0.87 ALDH1A1 (0.43) ALDH1A1HTTLMNAKDM4ETDP1
SCHEMBL18457050 0.86 ALDH1A1 (0.42) ALDH1A1HTTLMNAKDM4ETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11312690-B2 Compounds, compositions, methods for treating diseases, and methods for preparing compounds UNIVERSITY OF LOUSVILLE RESEARCH FOUNDATION, INC. (US) 2022-04-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11312690-B2 Compounds, compositions, methods for treating diseases, and methods for preparing compounds VHL, C5, KRAS ALDH1A1 475/4885HTT 173/4885LMNA 838/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback